Beck Mack & Oliver LLC Senseonics Holdings, Inc. Transaction History

Beck Mack & Oliver LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.37 - $0.52 $18,629 - $26,182	50,350 Added 49.93%	151,200 $60,000
Q1 2024 May 14, 2024	BUY	$0.5 - $0.73 $50,425 - $73,620	100,850 New	100,850 $53,000
Q2 2022 Aug 12, 2022	SELL	$0.94 - $1.94 $47,696 - $98,437	-50,741 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.54 - $3.71 $107 - $259	70 Added 0.14%	50,741 $100,000
Q4 2021 Jan 28, 2022	BUY	$2.58 - $3.91 $130,731 - $198,123	50,671 New	50,671 $135,000
Q3 2021 Nov 04, 2021	SELL	$2.77 - $4.05 $29,555 - $43,213	-10,670 Closed	0 $0
Q2 2021 Jul 28, 2021	BUY	$1.71 - $4.14 $18,245 - $44,173	10,670 New	10,670 $41,000

140

59.9M

393K

254K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $363M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Beck Mack & Oliver LLC, based on Form 13F filings with the SEC.

Stay updated on Beck Mack & Oliver LLC with notifications on news.